Abstract

BackgroundPregnant women with mild gestational hyperglycemia present high risk for hypertension, obesity and hyperglycemia, and appeared to reproduce the model of metabolic syndrome in pregnancy, with hyperinsulinemia and insulin resistance. Our clinical studies showed that mild gestational hyperglycemia or gestational diabetes are related to similar adverse maternal and perinatal outcomes. Hyperglycemia and other factors associated with diabetes generate reactive oxygen species that increase DNA damage levels. The aim of this study was to evaluate oxidative DNA damage in lymphocytes of pregnant women with diabetes or mild gestational hyperglycemia.MethodsThe study included 111 pregnant women distributed into three groups based on oral glucose tolerance test (OGTT) and glycemic profiles (GP), as follows: Normal OGTT and GP (control group); Normal OGTT and abnormal GP (mild gestational hyperglycemia group); Abnormal OGTT and GP (diabetic group). Maternal blood samples (5–10 mL) were collected and processed for determination of oxidative DNA damage by the comet assay, using Fpg and Endo III enzymes. Urine samples were also collected for determination of 8-OHdG concentrations by ELISA.ResultsSubjects in the diabetes group presented increased amount of oxidized purines, while mild gestational hyperglycemia women presented with increased oxidized pyrimidines, compared to the control group.ConclusionGestational, overt diabetes and mild gestational hyperglycemia, were all related to increased oxidative DNA damage. Diabetic pregnant women showed increased level of oxidative DNA damage, perhaps mainly due to hyperglycemia. On the other hand, oxidative DNA damage detected in women with mild gestational hyperglycemia might be associated with repercussions from obesity, hypertension and/or insulin resistance. Interestingly, the type of DNA base affected seemed to be dependent on the glycemic profile or oxidative stress.Electronic supplementary materialThe online version of this article (doi:10.1186/1758-5996-7-1) contains supplementary material, which is available to authorized users.

Highlights

  • The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study has demonstrated significant perinatal risks at levels of maternal hyperglycemia below values that are diagnostic for diabetes [1]

  • Since 1990, Rudge et al [4] have combined two parallel diagnostic tests, 100 g Oral Glucose Tolerance Test (OGTT) and Glycemic Profile (GP), to characterize the mild gestational hyperglycemia (MGH) pregnant group, women with positive screening for GDM, negative diagnosis for GDM but with hyperglycemia detected in the GP

  • We have shown that rats with mild or severe diabetes and their newborns exhibited increased oxidative DNA damage detected by the comet assay [15]

Read more

Summary

Introduction

The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study has demonstrated significant perinatal risks at levels of maternal hyperglycemia below values that are diagnostic for diabetes [1]. The MGH group represented 13.8% of positive screened pregnant women for GDM and, added to 7.0% of pregnancies complicated by diabetes, increase the occurrence of hyperglycemic disorders in pregnancy to about 20% [5]. These patients were at high risk for hypertension, obesity and hyperglycemia, and appeared to reproduce the model of metabolic syndrome (MS) in pregnancy, with hyperinsulinemia and insulin resistance, which continued six weeks postpartum [6]. The aim of this study was to evaluate oxidative DNA damage in lymphocytes of pregnant women with diabetes or mild gestational hyperglycemia

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call